This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Lluis Solá Carandell: Innovator in Pharmaceutical Co-Crystals
Introduction
Lluis Solá Carandell is a notable inventor based in Tarragona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals for pain treatment. His innovative work has the potential to enhance the efficacy of existing medications.
Latest Patents
One of Lluis Solá Carandell's key patents is titled "Co-crystals of duloxetine and COX-INHIBITORs for the treatment of pain." This invention relates to co-crystals of duloxetine combined with COX-INHIBITORs, which are used in the preparation of medicaments or pharmaceutical formulations aimed at treating pain. The patent highlights the processes for creating these co-crystals and their applications in medical treatments.
Career Highlights
Lluis Solá Carandell is associated with Laboratorios del Dr. Esteve S.A., where he has been instrumental in advancing pharmaceutical research. His work focuses on innovative solutions that address pain management through novel drug formulations.
Collaborations
Throughout his career, Lluis has collaborated with esteemed colleagues, including Helmut Heinrich Buschmann and Jordi Benet Buchholz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical development.
Conclusion
Lluis Solá Carandell's contributions to the field of pharmaceuticals, particularly through his patent on co-crystals for pain treatment, underscore his role as an innovator. His work continues to influence the development of effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile